Standardization and clinical management of lipoprotein(a) measurements

被引：13

作者：

Lippi, G ^{[1
]}

Guidi, G ^{[1
]}

机构：

[1] Univ Verona, Ctr Osped Clinicizzato, Ist Chim & Microscopia Clin, Lab Anal Chim Clin & Microbiol, I-37067 Valeggio Sul Mincio, VR, Italy

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 1998年 / 36卷 / 01期

关键词：

lipoprotein(a); measurement; immunoassay; standardization; risk factor;

D O I：

10.1515/CCLM.1998.003

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The present article proposes personal suggestions to improve determinations and clinical interpretation of results of lipoprotein(a) assays. Methods and procedures for sampling and quantification of the various isoforms of lipoprotein(a) in serum, plasma and urine are reviewed with the aim of improving the reliability and reproducibility of results and reinforcing the clinical utility of lipoprotein(a) measurements.

引用

页码：5 / 16

页数：12

共 184 条

[1] REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J].

ALBERS, JJ ;

TAGGART, HM ;

APPLEBAUMBOWDEN, D ;

HAFFNER, S ;

CHESNUT, CH ;

HAZZARD, WR .

BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) :293-296

[2] LP(A) LIPOPROTEIN - RELATIONSHIP TO SINKING PRE-BETA LIPOPROTEIN, HYPERLIPOPROTEINEMIA, AND APOLIPOPROTEIN-B [J].

ALBERS, JJ ;

CABANA, VG ;

WARNICK, GR ;

HAZZARD, WR .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (09) :1047-1054

[3]

ALBERS JJ, 1990, CLIN CHEM, V36, P2019

[4]

Albers JJ, 1996, J LIPID RES, V37, P192

[5]

Albers John J., 1994, Current Opinion in Lipidology, V5, P417, DOI 10.1097/00041433-199412000-00004

[6] EFFECT OF TESTOSTERONE ENANTHATE ON SERUM-LIPOPROTEINS IN MAN [J].

ANDERSON, RA ;

WALLACE, EM ;

WU, FCW .

CONTRACEPTION, 1995, 52 (02) :115-119

[7]

[Anonymous], 1994, CIRCULATION

[8] THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS [J].

ARMSTRONG, VW ;

CREMER, P ;

EBERLE, E ;

MANKE, A ;

SCHULZE, F ;

WIELAND, H ;

KREUZER, H ;

SEIDEL, D .

ATHEROSCLEROSIS, 1986, 62 (03) :249-257

[9] RELATIONSHIP OF APOLIPOPROTEIN-AI, APOLIPOPROTEIN-B AND LIPOPROTEIN LP(A) TO HEPATIC-FUNCTION OF LIVER RECIPIENTS DURING THE EARLY POSTTRANSPLANT PERIOD [J].

ARMSTRONG, VW ;

SCHUTZ, E ;

KALTEFLEITER, M ;

LUY, M ;

HELMHOLD, M ;

WIELAND, E ;

RINGE, B ;

OELLERICH, M .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (07) :485-493

[10] EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SUBJECTS WITH INCREASED LEVELS AND DIFFERENT ISOFORMS OF LIPOPROTEIN (A) [J].

AZNAR, J ;

ESTELLES, A ;

BRETO, M ;

ESPANA, F .

THROMBOSIS RESEARCH, 1993, 72 (05) :459-465

← 1 2 3 4 5 6 7 8 9 10 →